
Deep Dive: How Eli Lilly Became the First $1 Trillion Healthcare Company
The Rundown
00:00
Novo Nordisk's missteps and compounding impact
Zaid reviews Novo Nordisk's supply shortages, the rise of compounding pharmacies, and competitive fallout benefiting Lilly.
Play episode from 05:08
Transcript


